This is a Validated Antibody Database (VAD) review about mouse Mgmt, based on 5 published articles (read how Labome selects the articles), using Mgmt antibody in all methods. It is aimed to help Labome visitors find the most suited Mgmt antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Mgmt synonym: AGT; AI267024; Agat; methylated-DNA--protein-cysteine methyltransferase; 6-O-methylguanine-DNA methyltransferase; O-6-alkylguanine-DNA alkyltransferase; O-6-methylguanine-DNA-alkyltransferase
Novus Biologicals
mouse monoclonal (MT 23.2) |
| In order to describe the mechanism behind the association between single nucleotide polymorphism rs55705857 and glioma development., Novus Biologicals Mgmt antibody (Novus Biologicals, NB100-168) was used in immunohistochemistry on human samples (fig s1b). Sci Rep (2016) ncbi |
mouse monoclonal (MT 23.2) |
| In order to determine the promotion of genomic and phenotypic changes in glioblastoma cells by temozolomide, Novus Biologicals Mgmt antibody (Novus Biologicals, NB100-168) was used in western blot on human samples (fig 6). Cancer Cell Int (2016) ncbi |
mouse monoclonal (MT 23.2) |
| In order to investigate the role of protein stability in the choice of DNA repair mechanism, Novus Biologicals Mgmt antibody (Novus, NB100-168) was used in western blot on human samples at 1:1000 (fig s1d). Nat Commun (2014) ncbi |
Abcam
mouse monoclonal (MT3.1) |
| Abcam Mgmt antibody (Abcam, ab39253) was used in immunohistochemistry on human samples (fig s2). Cancer Lett (2015) ncbi |
mouse monoclonal (MT3.1) |
| Abcam Mgmt antibody (Abcam, ab39253) was used in western blot on human samples (fig 3d, 3e, 3f). Int J Oncol (2014) ncbi |
Articles Reviewed
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments